The holidays came early this year at the HoHoHoliday 5K in Toronto, which supports Make-A-Wish Canada! #TeamBlueRock sleighed it, as always.
BlueRock Therapeutics
Biotechnologieforschung
Cambridge, Massachusetts 65.605 Follower:innen
Striving to transform the treatment of disease by harnessing the power of cell therapy
Info
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.
- Website
-
http://www.bluerocktx.com
Externer Link zu BlueRock Therapeutics
- Branche
- Biotechnologieforschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Cambridge, Massachusetts
- Art
- Privatunternehmen
- Gegründet
- 2016
- Spezialgebiete
- Stem Cell Therapeutics, Engineered Cell Therapy, Cardiology, Neurology, Immunology, Regenerative Medicine und Cell+Gene
Orte
-
Primär
Wegbeschreibung
238 Main St
Cambridge, Massachusetts 02142, US
-
Wegbeschreibung
661 University Ave
Toronto, Ontario, CA
-
Wegbeschreibung
430 E 29th St
New York, 10016, US
-
Wegbeschreibung
Müllerstraße 178
Berlin, BE 13353, DE
Beschäftigte von BlueRock Therapeutics
Updates
-
What a year it's been! #BlueRockers made great strides towards our mission to discover and develop cell therapies that can change the way we treat disease and improve the lives of patients. #2024YearInReview
-
Team BlueRock was pumped to hit the parquet with Special Olympics Massachusetts at TD Garden for Bio-Ball! A great cause and a great group of people with infectious energy! #Community #GiveBack
-
-
#CellAndGenePodcast welcomed Amit Rakhit, MD, MBA for an in-depth discussion on innovative therapy options for #ParkinsonsDisease. Amit dives into how BlueRock’s bemdaneprocel offers a unique mechanism of action and how BlueRock is redefining treatment for degenerative diseases. #CellTherapy Erin Harris
🎙️ Episode 91 of Cell & Gene: The Podcast is available! For this episode, I invited BlueRock Therapeutics' Amit Rakhit, MD, MBA to get his take on therapy options for #Parkinsonsdisease (#PD). We discuss the limitations of current PD medications, how #celltherapies might offer a different approach to long-term symptom management, and how BlueRock is doing traditional #dopamine replacement therapy differently. It's a great episode. Subscribe and download wherever you #podcast to tune in. #cellandgenetherapy #cgt #neurologicaldisorder #celltherapy https://lnkd.in/eGFcxZUq
-
Toronto #BlueRockers raised nearly $2,500 for Daily Bread Food Bank at their annual fundraiser! We love dressing up for a good cause. #Community #GiveBack
-
-
Chief Scientific Officer Stefan Irion was on hand at the Bayer Berlin Co.Lab Opening! Berlin is a hub of scientific innovation and community and the Co.Lab will serve as a go-to incubator for Europe's top biotech and life science entrepreneurs. #TeamBayer
𝗢𝘂𝗿 𝗻𝗲𝘄 𝗕𝗮𝘆𝗲𝗿 𝗖𝗼.𝗟𝗮𝗯 𝗕𝗲𝗿𝗹𝗶𝗻 𝗶𝘀 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻 Join us for an exclusive tour of Bayer Co.Lab Berlin, where innovation meets collaboration. In this video, Ruth R. Shah, Head of Bayer Co.Lab Berlin, showcases our brand-new equipped facilities designed for startups who are pushing the boundaries in areas such as cell and gene therapy and oncology. Discover how we empower visionary entrepreneurs to transform groundbreaking ideas into impactful healthcare solutions. If you're a startup ready to make a difference, learn more about joining our vibrant community here: https://lnkd.in/eqij68Pe #TeamBayer #HealthForAll #HungerForNone #BayerCoLab
-
The holidays can be stressful for anyone. For those living with #ParkinsonsDisease, the holidays may pose additional challenges. Sharing a great article from Parkinson's Foundation with tips for navigating the holidays: https://lnkd.in/ep6nqBs7
-
-
BlueRockers collected 86 pair of prescription and non-prescription glasses for the Lions Club as part of October's Vision Month and #WorldSightDay. These items will be distributed to visually impaired adults and children in communities around the world who are underserved in eye health services. Learn more about our ophthalmology program: https://lnkd.in/e5UHNxCT #Ophthalmology #Community
-
-
"You have to realize that you need to be cared for, too, and the one whose going to make sure that happens, is you." - Patsy Ponder Dalton Listen to Patsy's experience on the Foundation's podcast: https://lnkd.in/ej6N2HcY Thank you, caregivers, for all that you do.
November is National Caregivers Month! This month and beyond, we honor the dedication and compassion of care partners in the Parkinson’s community. Your strength, love, and support truly inspire us. 🩵 Know that the Parkinson’s Foundation is here for you with resources at each stage of your care partner journey. Explore Parkinson.org/CarePartners to learn more and stay tuned on social media as we highlight resources to empower caregivers to find balance. #CaregiversMonth #Together4PD
-
-
BlueRock Therapeutics hat dies direkt geteilt
President and Chief Executive Officer at BlueRock Therapeutics | Driven by a personal mission to bring impactful therapies to patients and inspire the teams who develop them
Today, along with my Bayer colleague Sybil Williams, I had the pleasure of co-hosting Berlin’s Mayor Kai Wegner at the Bayer Research and Innovation Center (BRIC) in Cambridge. Mayor Wegner is leading a U.S. tour of government and business leaders from Berlin that are focused on connecting Berlin based healthcare companies with U.S. based companies and institutions. It was great to talk with the Mayor and this group about the work BlueRock Therapeutics is doing in #CellTherapy to help patients with #ParkinsonsDisease and #PrimaryPhotoreceptorDisease, as well as to showcase the robust and diverse life sciences ecosystem in Cambridge/Boston. #TeamBayer
-